scholarly article | Q13442814 |
P2093 | author name string | Ferrante A | |
Mack P | |||
Kumaratilake LM | |||
Prasertsiriroj V | |||
Widmer F | |||
Rathjen DA | |||
P2860 | cites work | Involvement of reactive oxygen metabolites in the candidacidal activity of human neutrophils stimulated by muramyl dipeptide or tumor necrosis factor. | Q54342216 |
Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro. | Q54346219 | ||
Improving on the formula | Q60063860 | ||
Augmentation of the human monocyte/macrophage chemiluminescence response during short-term exposure to interferon-gamma and tumour necrosis factor-alpha | Q67299759 | ||
The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects | Q67982535 | ||
Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation | Q68139886 | ||
Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha | Q69806791 | ||
Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils | Q70042400 | ||
Stimulation of neutrophils by tumor necrosis factor | Q70138077 | ||
Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor | Q70322634 | ||
Studies on heterologous resistance between Schistosoma mansoni and Fasciola hepatica in inbred rats | Q70329463 | ||
Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation | Q70504100 | ||
Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity | Q72660293 | ||
RAPID CHARCOAL ASSAY FOR INTRINSIC FACTOR (IF), GASTRIC JUICE UNSATURATED B12 BINDING CAPACITY, ANTIBODY TO IF, AND SERUM UNSATURATED B12 BINDING CAPACITY | Q78361535 | ||
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis | Q24564656 | ||
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 | ||
Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data | Q30906879 | ||
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors | Q34195478 | ||
Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release | Q35111591 | ||
Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes | Q35582778 | ||
Membrane proteins involved in the adherence of Plasmodium falciparum-infected erythrocytes to the endothelium | Q36168059 | ||
Human leukocyte acid hydrolases: Characterization of eleven lysosomal enzymes and study of reaction conditions for their automated analysis | Q39107231 | ||
The common mediator of shock, cachexia, and tumor necrosis. | Q39204110 | ||
Antiparasitic effects of tumour necrosis factor in vivo and in vitro | Q39602770 | ||
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites | Q40147908 | ||
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum | Q40153660 | ||
Antigenic structure of human tumour necrosis factor: Recognition of distinct regions of TNFα by different tumour cell receptors | Q43814208 | ||
Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height | Q47273348 | ||
Molecular Basis of Sequestration in Severe and Uncomplicated Plasmodium falciparum Malaria: Differential Adhesion of Infected Erythrocytes to CD36 and ICAM-l | Q47863824 | ||
Characterization of permeation pathways in the plasma membrane of human erythrocytes infected with early stages of Plasmodium falciparum: association with parasite development | Q47902878 | ||
Enhanced inhibition of in vitro multiplication of Plasmodium falciparum by stimulated human polymorphonuclear leucocytes. | Q47979786 | ||
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. | Q53438021 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Plasmodium falciparum | Q311383 |
Plasmodium chabaudi | Q7201860 | ||
P304 | page(s) | 2315-2323 | |
P577 | publication date | 1995-05-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice | |
P478 | volume | 95 |
Q33842644 | A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus |
Q33753828 | A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion |
Q37736263 | FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. |
Q35460907 | In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice |
Q33755132 | Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia |
Q92826319 | Modelling pathogen load dynamics to elucidate mechanistic determinants of host-Plasmodium falciparum interactions |
Q41915336 | Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels |
Q53070035 | Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation. |
Q34002249 | Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo |
Q39826884 | Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. |
Search more.